Jeremy Boussier

8PUBLICATIONS
54CO-AUTHORS
AutoimmunityWireless communication systems and technologies (incl. microwave and millimetrewave)Molecular targetsCardiology (incl. cardiovascular diseases)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.

|Jul 31, 2023
Anesthesia Teleconsultation: Quality, Medicoeconomic Interest, and Patient Satisfaction of Preoperative Assessment-A Prospective Observational Study.

Cyril Quemeneur, Frédéric Le Saché, Corentyn Ayrault

|Aug 19, 2021
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Nader Yatim, Jeremy Boussier, Pauline Tetu

|Jul 17, 2021
Platelet activation in critically ill COVID-19 patients.

Nader Yatim, Jeremy Boussier, Richard Chocron

|Feb 08, 2021
Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.

Laura I Levi, Veronica V Rezelj, Annabelle Henrion-Lacritick

|Nov 12, 2020
Chikungunya virus superinfection exclusion is mediated by a block in viral replication and does not rely on non-structural protein 2.

Jeremy Boussier, Laura Levi, James Weger-Lucarelli

Pageof 2

Frequent Collaborators

3 joint publications

Darragh Duffy

3 joint publications

Nader Yatim

2 joint publications

Laura I Levi

2 joint publications

Veronica V Rezelj